Home » Newsletters » BioWorld Science

BioWorld Science

June 26, 2017

View Archived Issues

Vaccibody reports results from phase I of VB C-01 study

[203Pb]-AR-RMX completes exploratory trial in somatostatin receptor-positive neuroendocrine tumors

Devonian to begin testing Thykamine in atopic dermatitis

Ultragenyx reaches agreement on burosumab BLA clinical data package

EMA gives positive opinion to Gilead Sciences' Vosevi

FDA gives breakthrough therapy designation to CR-845 from Cara Therapeutics

EMA's CHMP supports approval of adalimumab biosimilar Imraldi

Preliminary phase I/II results for epacadostat plus pembrolizumab in patients with SCCHN

Alexion Pharmaceuticals receives positive opinion from EMA to extend Soliris indication

Eisai seeks Japanese approval for Lenvima in HCC

EMA committee hands down positive opinion on pediatric formulation of Mimpara

Merck & Co. discloses leukotriene BLT1 receptor antagonists

Novel SSAO inhibitor UD-014 ameliorates experimental diabetic nephropathy

Gan & Lee Pharmaceuticals divulges CDK4 and CDK6 inhibitors

Naeja-Rgm Pharmaceuticals patents cephem derivatives

EMA's CHMP grants positive opinion for tivozanib for the first-line treatment of advanced RCC

Daiichi Sankyo develops probe to image B7-H3-expressing tumors

U.K. MHRA approves Redx's phase Ib/IIa trial of porcupine inhibitor RXC-004

AstraZeneca's Faslodex receives positive opinion in E.U.

Roche identifies cannabinoid CB2 receptor agonists

EMA supports E.U. approval of Maviret for HCV

Hinova Pharmaceuticals discovers URAT1 inhibitors

Takeda and Biological E partner on low-cost combination vaccines

Merck KGaA's cladribine earns positive opinion from CHMP for relapsing forms of multiple sclerosis

EMA committee recommends approval of Kisqali

Signs of efficacy seen with AMG-557 in systemic lupus erythematosus trial

FDA approves Bevyxxa for hospital and extended-duration prophylaxis of VTE

EC approves eslicarbazepine acetate monotherapy for newly diagnosed partial-onset epilepsy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...